Patient treatment preferences and the 5-HT1B/1D agonists.
about
Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment.The pharmacological management of migraine, part 1: overview and abortive therapy.The pharmacokinetics and clinical efficacy of AVP-825: a potential advancement for acute treatment of migraine.Patient preference in clinical trials for headache medication: the patient's view.Migraine recurrence is not associated with depressive or anxiety symptoms. Results of a randomized controlled trial.Two-layered dissolving microneedles for percutaneous delivery of sumatriptan in rats.
P2860
Patient treatment preferences and the 5-HT1B/1D agonists.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Patient treatment preferences and the 5-HT1B/1D agonists.
@ast
Patient treatment preferences and the 5-HT1B/1D agonists.
@en
Patient treatment preferences and the 5-HT1B/1D agonists.
@nl
type
label
Patient treatment preferences and the 5-HT1B/1D agonists.
@ast
Patient treatment preferences and the 5-HT1B/1D agonists.
@en
Patient treatment preferences and the 5-HT1B/1D agonists.
@nl
prefLabel
Patient treatment preferences and the 5-HT1B/1D agonists.
@ast
Patient treatment preferences and the 5-HT1B/1D agonists.
@en
Patient treatment preferences and the 5-HT1B/1D agonists.
@nl
P1476
Patient treatment preferences and the 5-HT1B/1D agonists.
@en
P2093
Ryan RE Jr
P304
P356
10.1001/ARCHINTE.161.21.2545
P407
P577
2001-11-01T00:00:00Z